# A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease

> **NCT06150820** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Astellas Gene Therapies** · enrollment: 119 (actual)

## Conditions studied

- Pompe Disease (Late-onset)

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT06150820
- **Lead sponsor:** Astellas Gene Therapies
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-02-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06150820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06150820, "A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06150820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*